Variant report

Variant	nsv1020970
Chromosome Location	chr5:50569183-50657424
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr5:50594422-50594425	H1-hESC	embryonic stem cell:	n/a	n/a
2	BATF	chr5:50571772-50571936	GM12878	blood:	n/a	n/a
3	BRCA1	chr5:50615674-50615690	Hela-S3	cervix:	n/a	n/a
4	CCNT2	chr5:50623371-50623558	K562	blood:	n/a	n/a
5	CEBPB	chr5:50642557-50642648	HepG2	liver:	n/a	chr5:50642618-50642629
6	CEBPB	chr5:50572120-50572466	A549	lung:	n/a	chr5:50572287-50572298
7	CEBPB	chr5:50572257-50572301	H1-hESC	embryonic stem cell:	n/a	chr5:50572287-50572298
8	CEBPB	chr5:50638055-50638383	HepG2	liver:	n/a	chr5:50638206-50638217 chr5:50638206-50638219
9	CEBPB	chr5:50569478-50569526	HepG2	liver:	n/a	n/a
10	CEBPB	chr5:50572053-50572521	ECC-1	luminal epithelium:	n/a	chr5:50572287-50572298
11	CEBPB	chr5:50572100-50572466	Hela-S3	cervix:	n/a	chr5:50572287-50572298
12	CEBPB	chr5:50572129-50572535	ECC-1	luminal epithelium:	n/a	chr5:50572287-50572298
13	CEBPB	chr5:50569158-50569717	Hela-S3	cervix:	n/a	n/a
14	CEBPB	chr5:50606524-50606711	HepG2	liver:	n/a	chr5:50606652-50606663
15	CEBPB	chr5:50572111-50572457	HepG2	liver:	n/a	chr5:50572287-50572298
16	CTCF	chr5:50643701-50643811	HepG2	liver:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
17	CTCF	chr5:50571810-50571975	MCF-7	breast:	n/a	n/a
18	CTCF	chr5:50643680-50643830	RPTEC	kidney:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
19	CTCF	chr5:50643700-50643850	BE2_C	brain:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
20	CTCF	chr5:50643575-50643980	HCT-116	colon:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
21	CTCF	chr5:50643680-50643830	SAEC	small airway:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
22	CTCF	chr5:50643590-50643844	ECC-1	luminal epithelium:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
23	CTCF	chr5:50643680-50643830	MCF-7	breast:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
24	CTCF	chr5:50643679-50643785	SK-N-SH_RA	brain:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
25	CTCF	chr5:50643700-50643850	Caco-2	colon:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
26	CTCF	chr5:50643660-50643810	RPTEC	kidney:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
27	CTCF	chr5:50643531-50643843	H1-hESC	embryonic stem cell:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
28	CTCF	chr5:50643680-50643830	AoAF	blood vessel:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
29	CTCF	chr5:50621643-50621704	MCF-7	breast:	n/a	n/a
30	CTCF	chr5:50643700-50643850	HMF	breast:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
31	CTCF	chr5:50643700-50643850	HCT-116	colon:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
32	CTCF	chr5:50571800-50572016	MCF-7	breast:	n/a	n/a
33	CTCF	chr5:50643660-50643810	HEEpiC	esophagus:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
34	CTCF	chr5:50634460-50634610	GM12878	blood:	n/a	n/a
35	CTCF	chr5:50597360-50597510	NHDF-neo	bronchial:	n/a	n/a
36	CTCF	chr5:50643700-50643850	HEK293	kidney:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
37	CTCF	chr5:50571716-50572082	MCF-7	breast:	n/a	n/a
38	CTCF	chr5:50643700-50643850	Hela-S3	cervix:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
39	CTCF	chr5:50643617-50643917	HepG2	liver:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
40	CTCF	chr5:50643720-50643870	HCT-116	colon:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
41	CTCF	chr5:50643680-50643830	HEEpiC	esophagus:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
42	CTCF	chr5:50571800-50571950	GM12874	blood:	n/a	n/a
43	CTCF	chr5:50643748-50643759	Kidney_OC	kidney:	n/a	n/a
44	CTCF	chr5:50643620-50643809	ECC-1	luminal epithelium:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
45	CTCF	chr5:50643620-50643770	HEK293	kidney:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
46	CTCF	chr5:50643680-50643830	NHDF-neo	bronchial:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
47	CTCF	chr5:50643594-50643893	GM12878	blood:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
48	CTCF	chr5:50643660-50643810	MCF-7	breast:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
49	CTCF	chr5:50643660-50643810	HMEC	breast:	n/a	chr5:50643727-50643745 chr5:50643722-50643743
50	CTCF	chr5:50571840-50571990	GM12865	blood:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:50575784-50575834	CMK	blood:	n/a
2	chr5:50575784-50575834	CMK	blood:	n/a
3	chr5:50575784-50575834	AoSMC	blood vessel:	n/a
4	chr5:50575784-50575834	IMR90	lung:	fetal
5	chr5:50575784-50575834	HCM	heart:	n/a
6	chr5:50575784-50575834	GM19239	blood:	n/a
7	chr5:50575784-50575834	NH-A	brain:	n/a
8	chr5:50575784-50575834	NHDF-neo	bronchial:	n/a
9	chr5:50575784-50575834	Hepatocyte	liver:	n/a
10	chr5:50575784-50575834	HUVEC	blood vessel:	n/a
11	chr5:50575784-50575834	GM06990	blood:	n/a
12	chr5:50575784-50575834	NHBE	bronchial:	n/a
13	chr5:50575784-50575834	HEK293	kidney:	embryo
14	chr5:50575784-50575834	SK-N-SH	brain:	n/a
15	chr5:50575784-50575834	A549	lung:	n/a
16	chr5:50575784-50575834	RPTEC	kidney:	n/a
17	chr5:50575784-50575834	ECC-1	luminal epithelium:	n/a
18	chr5:50575784-50575834	ProgFib	skin:	n/a
19	chr5:50575784-50575834	H1-hESC	embryonic stem cell:	embryo
20	chr5:50575784-50575834	NT2-D1	testis:	n/a
21	chr5:50575784-50575834	AG04449	skin:	fetal
22	chr5:50575784-50575834	SK-N-SH_RA	brain:	n/a
23	chr5:50575784-50575834	HRPEpiC	eye:	n/a
24	chr5:50575784-50575834	HCT-116	colon:	n/a
25	chr5:50575784-50575834	NB4	blood:	n/a
26	chr5:50575784-50575834	PFSK-1	brain:	n/a
27	chr5:50575784-50575834	AG09319	gingival:	n/a
28	chr5:50575784-50575834	HepG2	liver:	n/a
29	chr5:50575784-50575834	AG09309	skin:	n/a
30	chr5:50575784-50575834	HCF	heart:	n/a
31	chr5:50575784-50575834	GM12891	blood:	n/a
32	chr5:50575784-50575834	BE2_C	brain:	n/a
33	chr5:50575784-50575834	GM12878	blood:	n/a
34	chr5:50575784-50575834	Caco-2	colon:	n/a
35	chr5:50575784-50575834	U87	brain:	n/a
36	chr5:50575784-50575834	SK-N-MC	brain:	n/a
37	chr5:50575784-50575834	HEEpiC	esophagus:	n/a
38	chr5:50575784-50575834	PrEC	prostate:	n/a
39	chr5:50575784-50575834	HAEpiC	amniotic membrane:	n/a
40	chr5:50575784-50575834	MCF10A-Er-Src	breast:	n/a
41	chr5:50575784-50575834	LNCaP	prostate:	n/a
42	chr5:50575784-50575834	BJ	skin:	n/a
43	chr5:50575784-50575834	PANC-1	pancreas:	n/a
44	chr5:50575784-50575834	HMEC	breast:	n/a
45	chr5:50575784-50575834	AG04450	lung:	fetal
46	chr5:50575784-50575834	Hela-S3	cervix:	n/a
47	chr5:50575784-50575834	HL-60	blood:	n/a
48	chr5:50575784-50575834	HCPEpiC	choroid plexus:	n/a
49	chr5:50575784-50575834	HRE	kidney:	n/a
50	chr5:50575784-50575834	GM12892	blood:	n/a

No.	Distal block	Cell Line	Cell type
1	chr5:50572356..50575340-chr5:50576089..50578064,2	MCF-7	breast:
2	chr5:50572356..50575340-chr5:50576089..50578064,2	MCF-7	breast:
3	chr5:50571410..50572428-chr5:50643087..50644166,3	MCF-7	breast:
4	chr5:50258485..50259288-chr5:50571370..50571987,2	MCF-7	breast:
5	chr5:50615231..50617693-chr5:50621109..50623686,2	K562	blood:
6	chr5:50257889..50259548-chr5:50643207..50644436,8	MCF-7	breast:
7	chr5:50258356..50259362-chr5:50643286..50644180,12	MCF-7	breast:
8	chr5:50260308..50260944-chr5:50571869..50572389,2	MCF-7	breast:
9	chr5:50615231..50617693-chr5:50621109..50623686,2	K562	blood:
10	chr5:50571410..50572428-chr5:50643087..50644166,3	MCF-7	breast:
11	chr5:50258512..50259359-chr5:50571455..50572343,4	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ISL1-2	chr5:50571087-50571568	NONHSAT101386

Variant related genes	Relation type
ENSG00000240627	TF binding region
ENSG00000238702	TF binding region
ENSG00000240627	CpG island
ENSG00000238702	CpG island

Extended variants
information (count: 1198 )
Associated
traits (count: 86 )

Variant overlapped rSNPs/rCNVs (count:1198 , 50 per page) page: 1 2 3 4 5 6 7 ... 24

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs543724456	chr5:50569215-50569216	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs557332841	chr5:50569254-50569255	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs145652979	chr5:50569321-50569322	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs373481198	chr5:50569353-50569354	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs191684530	chr5:50569354-50569355	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs531962772	chr5:50569389-50569390	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs147722515	chr5:50569403-50569404	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs564130102	chr5:50569447-50569448	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs183788676	chr5:50569484-50569485	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs548301187	chr5:50569498-50569499	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs76437338	chr5:50569499-50569500	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs188133648	chr5:50569544-50569545	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs142491176	chr5:50569593-50569594	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs566607915	chr5:50569607-50569608	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs533385709	chr5:50569683-50569684	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs550051770	chr5:50569721-50569722	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs570375034	chr5:50569757-50569758	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs533967328	chr5:50569787-50569788	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs113732110	chr5:50569792-50569793	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs549319463	chr5:50569798-50569799	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs565960590	chr5:50569817-50569818	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs535099540	chr5:50569823-50569824	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs180831976	chr5:50569967-50569968	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs374907063	chr5:50570019-50570020	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs369259437	chr5:50570020-50570021	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs570338600	chr5:50570026-50570027	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs373362059	chr5:50570135-50570136	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs185884112	chr5:50570157-50570158	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs558904468	chr5:50570196-50570197	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs190310068	chr5:50570214-50570215	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs542571106	chr5:50570227-50570228	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs147580383	chr5:50570246-50570247	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs182025695	chr5:50570276-50570277	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs185746508	chr5:50570299-50570300	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs564682421	chr5:50570395-50570396	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs533346836	chr5:50570405-50570406	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs543563119	chr5:50570464-50570465	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs149052822	chr5:50570506-50570507	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs190109703	chr5:50570560-50570561	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs77000469	chr5:50570584-50570585	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs566048149	chr5:50570645-50570646	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs143051455	chr5:50570708-50570709	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs551901133	chr5:50570717-50570718	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs377743466	chr5:50570782-50570783	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs537549818	chr5:50570884-50570885	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs370863958	chr5:50570885-50570886	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs79501030	chr5:50570897-50570898	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs181050973	chr5:50570900-50570901	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs536526700	chr5:50570916-50570917	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs553029511	chr5:50570939-50570940	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:86)

Disease	PMID	Source
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Colorectal cancer	21645411	CNVD
Gastric cancer	22152101	CNVD
Oesophago-gastric ulcer	22152101	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Multiple myeloma	17550852	CNVD
Thoracic aortic aneurysm	21092924	CNVD
DNA damage stimulus	22844521	CNVD
DNA repair	22844521	CNVD
Breast cancer	21785460	CNVD
Spinal muscular atrophy	22422766	CNVD
Spinal muscular atrophy	22558076	CNVD
Spinal muscular atrophy	21320981	CNVD
Spinal muscular atrophy	21762474	CNVD
Cancer	16751803	CNVD
Autism	22495311	CNVD
Intellectual disability	22102821	CNVD
Prostate cancer	21965145	CNVD
Cancer	21183584	CNVD
Ovarian cancer	20844748	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Non-small cell lung cancer	21829676	CNVD
Breast cancer	22032731	CNVD
Esophageal cancer	20955586	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Breast cancer	17393978	CNVD
Cancer	21359685	CNVD
adenomatous polyposis	22470819	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Acute myeloid leukemia	20729466	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Hepatocellular carcinoma	16750200	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21364760	CNVD
Oral cancer	21386901	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Bladder cancer	21909424	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
small cell lung cancer	20016488	CNVD
Myelofibrosis	22110671	CNVD
Lung cancer	21911935	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:92 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:50567200-50574400	Weak transcription	HUES64 Cell Line	embryonic stem cell
2	chr5:50568200-50569800	Enhancers	Hela-S3	cervix
3	chr5:50568600-50569800	Enhancers	Breast Myoepithelial Primary Cells	Breast
4	chr5:50568800-50569200	Enhancers	ES-I3 Cell Line	embryonic stem cell
5	chr5:50569200-50574200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
6	chr5:50569800-50570000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
7	chr5:50569800-50574400	Weak transcription	Breast Myoepithelial Primary Cells	Breast
8	chr5:50570000-50574200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
9	chr5:50573400-50573600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
10	chr5:50573800-50575800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
11	chr5:50574200-50574400	Enhancers	ES-I3 Cell Line	embryonic stem cell
12	chr5:50574200-50574800	Enhancers	H9 Cell Line	embryonic stem cell
13	chr5:50574200-50576200	Enhancers	iPS-18 Cell Line	embryonic stem cell
14	chr5:50574200-50576400	Enhancers	HUES48 Cell Line	embryonic stem cell
15	chr5:50574200-50576800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
16	chr5:50574200-50576800	Enhancers	Fetal Heart	heart
17	chr5:50574200-50577000	Enhancers	HUES6 Cell Line	embryonic stem cell
18	chr5:50574200-50577000	Enhancers	iPS-15b Cell Line	embryonic stem cell
19	chr5:50574200-50577200	Enhancers	iPS-20b Cell Line	embryonic stem cell
20	chr5:50574400-50574600	ZNF genes & repeats	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
21	chr5:50574400-50574600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
22	chr5:50574400-50574800	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
23	chr5:50574400-50574800	Enhancers	H1 Cell Line	embryonic stem cell
24	chr5:50574400-50574800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
25	chr5:50574400-50574800	Enhancers	Breast Myoepithelial Primary Cells	Breast
26	chr5:50574400-50576000	Enhancers	Fetal Stomach	stomach
27	chr5:50574400-50577000	Enhancers	HUES64 Cell Line	embryonic stem cell
28	chr5:50574400-50577000	Enhancers	Cortex derived primary cultured neurospheres	brain
29	chr5:50574600-50574800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
30	chr5:50574600-50576000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
31	chr5:50574600-50576400	Enhancers	Brain Germinal Matrix	brain
32	chr5:50574600-50576800	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
33	chr5:50574800-50577000	Enhancers	ES-I3 Cell Line	embryonic stem cell
34	chr5:50574800-50578200	Weak transcription	H9 Cell Line	embryonic stem cell
35	chr5:50574800-50578200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
36	chr5:50574800-50578400	Weak transcription	H1 Cell Line	embryonic stem cell
37	chr5:50575400-50576600	Enhancers	Fetal Brain Female	brain
38	chr5:50575800-50576400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
39	chr5:50576000-50576400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
40	chr5:50576400-50578200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
41	chr5:50577000-50577400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
42	chr5:50577000-50578200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
43	chr5:50577000-50578200	Weak transcription	HUES6 Cell Line	embryonic stem cell
44	chr5:50577200-50578200	Weak transcription	iPS-20b Cell Line	embryonic stem cell
45	chr5:50577800-50579000	Enhancers	iPS-15b Cell Line	embryonic stem cell
46	chr5:50578000-50578200	Enhancers	HUES48 Cell Line	embryonic stem cell
47	chr5:50578200-50578400	Enhancers	iPS-20b Cell Line	embryonic stem cell
48	chr5:50578200-50578400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
49	chr5:50578200-50578400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
50	chr5:50578200-50578800	Enhancers	H9 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links